PXAI Audio Feed
24/04 20:50 statnews.com

STAT+: A biotech VC on what Eli Lilly saw in a struggling cancer startup for $3.2B

THE READOUT LOUDPHARMACEUTICAL INDUSTRYELI LILLYBIOTECHPOLITICSVENTURE CAPITAL
24/04 16:19 statnews.com

STAT+: Sanofi MS drug gets positive review in Europe following FDA

DRUG DEVELOPMENTTHE READOUTPOLITICSDRUG PRICINGRESEARCHPHARMACEUTICALS
22/04 17:40 statnews.com

STAT+: The latest biotech news: RevMed, Roche, Kyverna CAR-T therapy

THE READOUTDRUG DEVELOPMENTBIOTECHPHARMARESEARCHPOLITICS
21/04 16:37 statnews.com

STAT+: Kelonia Therapeutics’ road from floundering to $3 billion

THE READOUTBUSINESSDRUG PRICESDRUG DEVELOPMENTPOLITICSPHARMA
20/04 16:29 statnews.com

STAT+: Finally cracking KRAS as a druggable target

BIOTECHNOLOGYBUSINESSDRUG DEVELOPMENTPOLITICSDRUG PRICESTHE READOUT
17/04 20:37 statnews.com

STAT+: A pancreatic cancer expert on why Revolution Medicines’ study could ‘open up a new era’ of treatment

PHARMACEUTICAL INDUSTRYTHE READOUT LOUDCANCERJUSTICEBIOTECHPOLITICS
17/04 16:40 statnews.com

STAT+: FDA eyes expanding testosterone therapy for libido

DRUG PRICESBIOTECHPOLITICSBIOTECHNOLOGYBUSINESSTHE READOUT
16/04 22:37 statnews.com

A pancreatic cancer breakthrough, and new hope for an off-the-shelf CAR-T treatment

CANCERTHE READOUT LOUDCLINICAL TRIALSBIOTECHNOLOGYPHARMACEUTICALSPOLITICS
16/04 18:18 statnews.com

STAT+: Cochrane review reignites Alzheimer’s amyloid wars

PHARMAPOLITICSTHE READOUTDIPLOMACYDRUG DEVELOPMENTRESEARCH
16/04 18:18 statnews.com

STAT+: Cochrane review reignites Alzheimer’s amyloid wars

PHARMAPOLITICSTHE READOUTDIPLOMACYDRUG DEVELOPMENTRESEARCH
Comments
Loading...
0